10x Insights
Loading account…
Companies / Industrials / Evolent Health, Inc.
EVH

Evolent Health, Inc.

IndustrialsProfessional Services
Ticker EVHARLINGTON, VAFiscal year ends DecemberBook value per share $3.41Diluted shares 112.2M

Evolent Health, Inc. (NYSE: EVH) is a market leader in specialty care management and value-based care solutions serving health plans, providers, and other risk-bearing payers across the United States. The company operates through a single reportable segment, delivering integrated technology-enabled services designed… From the company’s description.

Fiscal year 2025 · ends 12-31Changes are against fiscal 2024The amber dot is the latest twelve months, to 2026-06-30
Sales & profitability
$1.88B
−26.6% year over year
Last 12 mo $2.10B
-21.86%
−20.3 percentage points
Last 12 mo -20.39%
$-534.51M
−767.4% year over year
Last 12 mo $-504.99M
-32.86%
−27 percentage points
Last 12 mo -131.77%
Cash & financing
$38.84M
+107.0% year over year
Last 12 mo $54.32M
$4.76M
+177.6% year over year
Last 12 mo $24.34M
2.34
Was 0.66× a year earlier
Last 12 mo 2.52
114.2M
−0.4% year over year
Last 12 mo 112.2M

Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.

What Evolent Health, Inc. does

In the company’s own words

Evolent Health, Inc. (NYSE: EVH) is a market leader in specialty care management and value-based care solutions serving health plans, providers, and other risk-bearing payers across the United States. The company operates through a single reportable segment, delivering integrated technology-enabled services designed to improve clinical outcomes while reducing healthcare costs for patients with complex conditions including cancer, cardiovascular disease, and musculoskeletal diagnoses.

Founded in 2011 through a partnership between management, the University of Pittsburgh Medical Center, and The Advisory Board Company, Evolent has grown organically and through strategic acquisitions to build a comprehensive platform addressing the healthcare industry's shift toward value-based payment models. The company's primary solution, Specialty Care Management Services, represents the majority of revenues and focuses on oncology, cardiology, and musculoskeletal care management. This solution combines three core capabilities: assembling high-performance provider networks, designing evidence-based clinical pathways, and deploying proprietary specialty care management technology including the CareProTM platform.

Evolent's secondary offering, Administrative Services, includes its proprietary Identifi® platform alongside comprehensive health plan administration capabilities spanning third-party administration, pharmacy benefit management, risk management, analytics and reporting, and leadership services. The company serves multiple customer types including health systems, providers, physicians, health plans, and delegated arrangements across Medicare, Medicaid, and commercial markets.

The company's competitive strengths include its provider-heritage brand identity, early innovation in value-based care, differentiated integrated service offerings, proprietary technology platforms, and partnership-driven business model that aligns incentives through risk-sharing arrangements. Evolent's revenue model is primarily based on fixed fees per member per month, with certain services billed on a per-case basis. The business benefits from scale as centralized resources and technologies are leveraged across an expanding partner base.

Notable acquisitions shaping the current business include New Century Health in 2018, which formed the foundation of the specialty care management solution, along with subsequent acquisitions of companies specializing in oncology, cardiology, radiology, musculoskeletal, and genetics care management. The company maintains its website at www.evolenthealth.com.

Company details
Sector
Industrials
Industry
Professional Services
Headquarters
ARLINGTON, VA
Fiscal year end
December
CIK
1628908
SIC
8741

Financial performance, year by year

Fiscal 2015–2025 · USD
$-843.44M$83.34M$1.01B$1.94B$2.86B20152016201720182019202020212022202320242025Last 12 moLast 12 monthsLast 12 months

The full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.

Ownership

Who owns Evolent Health, Inc. — and what changed

Funds as of 2026Q2 · superinvestors as of 2026-06-30

154
funds hold it
0 of 35
superinvestors hold it
$102.92M
held by funds, at market
19.0%
of shares held by funds
2
bond issues held by funds

Largest fund holders · Evolent Health, Inc.’s weight in each

VANGUARD TOTAL STOCK MARKET INDEX FUND
VTI · VANGUARD INDEX FUNDS
0.00%of fund net assets
iShares Russell 2000 ETF
IWM · iShares Trust
0.02%of fund net assets
VANGUARD EXTENDED MARKET INDEX FUND
VXF · VANGUARD INDEX FUNDS
0.01%of fund net assets
Fidelity Small Cap Index Fund
FSSNX · Fidelity Salem Street Trust
0.01%of fund net assets
iShares Russell 2000 Value ETF
IWN · iShares Trust
0.03%of fund net assets

Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.

Evolent Health, Inc.’s bonds, as funds hold them

Funds report holding 2 issues of Evolent Health, Inc.’s debt, $22.22M at market value — what funds hold, not the company’s total debt. Weighted-average coupon 3.78%, maturing 2029 to 2031.

Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.

Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.

Connected research

Put this business in context.

Compare this company with peers, find it in your funds and follow its financial history with your connected AI:

  • “How do Evolent Health, Inc. and its peers compare on margins and cash generation over ten years?”
  • “Where did five years of Evolent Health, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
  • “What changed in Evolent Health, Inc.'s last four quarterly filings that the numbers alone won't show?”
See how it works →All research tools with a subscription. Use your own AI account.